Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool

BACKGROUND: Preclinical research suggests that cannabidiol (CBD) may have therapeutic potential in pathological anxiety. Dosing guidelines to inform future human studies are however lacking. AIM: We aimed to predict the therapeutic window for anxiety-reducing effects of CBD in humans based on precli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwee, Caroline MB, van Gerven, Joop MA, Bongaerts, Fleur LP, Cath, Danielle C, Jacobs, Gabriël, Baas, Johanna MP, Groenink, Lucianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716490/
https://www.ncbi.nlm.nih.gov/pubmed/36239014
http://dx.doi.org/10.1177/02698811221124792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716490/
https://www.ncbi.nlm.nih.gov/pubmed/36239014
http://dx.doi.org/10.1177/02698811221124792

Ejemplares similares